Last reviewed · How we verify
optimizing therapeutic treatments
At a glance
| Generic name | optimizing therapeutic treatments |
|---|---|
| Sponsor | Hamilton Health Sciences Corporation |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. (NA)
- Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation (NA)
- Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling (PHASE1)
- Optimizing Y90 Therapy for Radiation Lobectomy
- The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders (NA)
- Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial) (PHASE2)
- Improving Preterm Kidney Outcomes With Caffeine (PHASE2)
- Optimizing Functional Recovery After Breast Cancer Treatment (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: